Marie-Christine Chartier-Harlin
Team "Early Stages of Parkinson's Disease" of the Jean-Pierre Aubert Research Center
INSERM UMR-S1172, CHRU Lille, University of Lille 1 and Lille 2
Marie-Christine Chartier-Harlin has not added Biography.
If you are Marie-Christine Chartier-Harlin and would like to personalize this page please email our Author Liaison for assistance.
Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study.
Human molecular genetics Jan, 2003 | Pubmed ID: 12490535
S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: evidence for an age-dependent relationship.
Movement disorders : official journal of the Movement Disorder Society Feb, 2003 | Pubmed ID: 12539205
CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease.
Annals of neurology Mar, 2004 | Pubmed ID: 14991823
UCHL1 is a Parkinson's disease susceptibility gene.
Annals of neurology Apr, 2004 | Pubmed ID: 15048890
Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease.
Neuroscience letters May, 2004 | Pubmed ID: 15193763
Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.
Lancet Sep 25-Oct 1, 2004 | Pubmed ID: 15451224
Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.
Neuroscience letters Jul, 2005 | Pubmed ID: 15925094
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
JAMA : the journal of the American Medical Association Aug, 2006 | Pubmed ID: 16896109
Prenatal stress has pro-inflammatory consequences on the immune system in adult rats.
Psychoneuroendocrinology Feb, 2007 | Pubmed ID: 17240075
Genomic investigation of alpha-synuclein multiplication and parkinsonism.
Annals of neurology Jun, 2008 | Pubmed ID: 18571778
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation.
Neurobiology of aging Oct, 2011 | Pubmed ID: 20096956
Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
Annals of neurology May, 2011 | Pubmed ID: 21391235
SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes.
Human mutation Apr, 2011 | Pubmed ID: 21412942
Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease.
Neurobiology of aging Nov, 2011 | Pubmed ID: 21782285
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.
Lancet neurology Oct, 2011 | Pubmed ID: 21885347
Translation initiator EIF4G1 mutations in familial Parkinson disease.
American journal of human genetics Sep, 2011 | Pubmed ID: 21907011
Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.
Movement disorders : official journal of the Movement Disorder Society Oct, 2013 | Pubmed ID: 23913756
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
Neurobiology of aging Jan, 2014 | Pubmed ID: 23962496
Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease.
Neurobiology of disease Mar, 2014 | Pubmed ID: 24269915
Alpha-synuclein repeat variants and survival in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society Jul, 2014 | Pubmed ID: 24578302
Deregulation of protein translation control, a potential game-changing hypothesis for Parkinson's disease pathogenesis.
Trends in molecular medicine Aug, 2015 | Pubmed ID: 26091824
版权所属 © 2025 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。
我们使用 cookie 来增强您在我们网站上的体验。
继续使用我们的网站或单击“继续”，即表示您同意接受我们的 cookie。